Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007
Clinical trial NCT02301234 · COMPLETED
Trial details
- NCT number
- NCT02301234
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-25
- Primary completion
- 2016-09-19
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.